Table 2.
Transcripts | Sequence (5′–3′) | Product Size (bp) | |
---|---|---|---|
Oxidative | Nrf2 | F: GGCCGCCTTGAAGCTCATCTC | 177 |
stress | R: CTTGCCTCTCCTGCGTATATCTCG | ||
Keap1 | F: TTTTCAAGACCTCACCCTCCATAAACC | 113 | |
R: AGTAGCCCAAGGACTGCCGATAG | |||
HO-1 | F: AGAGCCAGGAGAACGGTCACC | 114 | |
R: TGCTTGTCCTCTCGCTTTCTTTCC | |||
CAT | F: ATGGACCAATGTGCGTGACTGAC | 104 | |
R: CATGCGGCTCTCCTTCACAACAG | |||
SOD1 | F:TCTCTCTGACTGGACCACACTGC | 100 | |
R: GTTAGCGTGCTCTCGTTGTCTCC | |||
NQO1 | F: GCTCTCACGGCACGACATCAC | 84 | |
R: TCCTTCCACGCTTCTCCCATCTC | |||
GST | F: GACTTTCTTGTGGGGAACCGACTC | 102 | |
R: AGGAAACCCAGAAAGCACAGCAG | |||
GCLM | F: TGTTGTGTGATGCCACCTGATCTC | 150 | |
R: CCATTCGTGTGCTTTGACGTTCTG | |||
GCLC | F: TTCAGGTGACATTCCAGGCTTGC | 108 | |
R: AGAACGGAGATGCAGCACTCAATG | |||
Detoxification | CYP1A1 | F: AGGACGGAGGCTGACAAGGTG | 104 |
R: AGGATGGTGGTGAGGAAGAGGAAG | |||
CYP1A4 | F: AATGCTCGTTTCAGTGCCTTC | 127 | |
R: CCTCCCCTGTCCTTTTCTCC | |||
CYP3A4 | F: GACGTGCAGAAGCGACTCCAG | 161 | |
R: TTCTTGCAGATCCGCTCAATCCG | |||
Inflammation | IL-10 | F: CAACCTGCTGCTGAGCCTGAAG | 133 |
R: CGCCTTGTAGATGCCGTTCTCG | |||
IL-16 | F: TCAACGGACTCGCAGTAACTCAAC | 95 | |
R: GATCTCTGAAGGGCACGGCTTTC | |||
IL-18 | F: ACCCTCCATCGCTTCCTTCGG | 113 | |
R: CCGCTGCCAGATTTCATCTCCTG | |||
TNF-α | F: CCGTGGTCAGTTTCCATCAGG | 117 | |
R: ACTTTGCAGTTAGGTGACGCT | |||
NF-κB | F: GGAGCAGTGGCGGTGTCAAC | 126 | |
R: AGTGCAGTTCATGTCATCGGTCTC | |||
Sirt1 | F: TGACAGAGCCTCACATGCAAGTTC | 144 | |
R: GGTGGAGGGATTGTTTCTGGTAGC | |||
Apoptosis | Caspase3 | F: TGAGGCAGACAGTGGACCAGATG | 110 |
R: CTGCATTCCGCCAGGAGTAATAGC | |||
Caspase9 | F: TGGATTGCGATTCACCCGAAGATG | 83 | |
R: ATTACCCGAGGGAGCCTGGAAAG | |||
Bax | F: GCGGACGGAGCCTTCAACTG | 84 | |
R: CTGCGAGAACAGAGCCTTGATGG | |||
Bcl-2 | F: GAGTTCGGCGGCGTCATGTG | 155 | |
R: CCATACAACTCCACGAAGGCATCC | |||
P53 | F: ACTGCTACGTCGCGGCTCTC | 199 | |
R: CGCTGGCAAGGCTGGTGAAC | |||
Internal | β-actin | F: ATGTCGCCCTGGATTTCG | 62 |
reference | R: ATGTCGCCCTGGATTTCG |
Nrf2, nuclear factor erythroid 2-related factor 2; Keap1, Kelch-like ECH-associated protein; HO-1, heme oxygenase 1; CAT, catalase; SOD, superoxide dismutase; NQO1, NAD(P)H quinone oxidoreductase 1; GCLC, glutamate cysteine ligase catalyzes subunits; GCLM, glutamic acid cysteine ligase modified subunit; Caspase-1, cysteine-dependent aspartate-directed protease-1; CYP1A1, cytochrome P450 1A1; CYP1A4, cytochrome P450 1A4; CYP3A4, cytochrome P450 3A4; IL-10, interleukin-10; IL-16, interleukin-16; IL-18, interleukin- 18; TNF-α, tumor necrosis factor α; NF-κB, nuclear factor-κb; Sirt1, Sirtuin 1; Caspase-3, cysteine-dependent aspartate-directed protease-3; Caspase-9, cysteine-dependent aspartate-directed protease-9; Bax, Bcl-2 associated X; Bcl-2, Mus musculus B cell leukemia/lymphoma 2.